Figure 1From: Randomized placebo-controlled trial of high-dose prenatal third-trimester vitamin D3 supplementation in Bangladesh: the AViDD trial CONSORT diagram depicting the flow of participants through the study. Data for all subjects were analyzed at baseline. In longitudinal analyses, 74 participants in the placebo group and 77 participants in the vitamin D group contributed at least one biochemical value beyond baseline.Back to article page